发现了使用机器学习和分子对接方法的新型抗乙胆酶
Wei Xiao1, Liu-Zhen Chen1, Jun Chang1
1School of Life Science, Jiangxi Science & Technology Normal University, Nanchang, Jiangxi, People's Republic of China.
Drug design, development and therapy
|June 19, 2025
概括
通过使用混合数据集来改进抗乙胆酶的机器学习模型. 这种方法确定了阿尔茨海默病治疗的六种强效,为目前的疗法提供了更安全的替代方案.
科学领域:
- 计算化学和药理学计算化学和药理学
- 药物的发现和开发.
- 生物信息学和机器学习
背景情况:
- 阿尔茨海默病 (AD) 治疗受到当前药物无法逆转进展及其相关毒性的限制.
- 开发有效的抗乙胆酶被缺乏全面的公开数据所阻碍.
- 现有的机器学习模型在仅使用非小分子数据预测活性时往往表现不佳.
研究的目的:
- 为应对在抗乙胆酶发现中机器学习模型有限的数据的挑战.
- 开发一种新的机器学习模型,利用混合数据集进行增强的预测.
- 为了发现新的,更安全,更少有毒的抗乙胆酶,以改善阿尔茨海默病的治疗.
主要方法:
- 一个随机森林分类器模型被训练在一个混合数据集,包括非小分子和.
- 该模型被用来选一个定制的类库,以检测潜在的抗乙胆酶活性.
- 分子对接评估了结合亲缘关系,排名第一的经过实验验证.
主要成果:
- 六种 (IFLSMC,WCWIYN,WIGCWD,LHTMELL,WHLCVLF,VWIIGFEHM) 被选择用于实验验证.
- 实验分析确定了它们对乙胆酶的抑制度,其值从0.007到10.6μmol/L不等.
- 与仅在小分子上训练的模型相比,开发的模型在区分活性中表现出更高的准确性.
结论:
- 混合数据集显著提高了用于类药物发现的机器学习模型的预测能力.
- 已识别的强效代表了开发更安全,更有效的阿尔茨海默病治疗方法的有希望的候选人.
- 这项研究强调了整合不同类型数据的潜力,以克服发现新疗法剂的局限性.
更多相关视频
13:31Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis
Published on: February 12, 2015
8.9K
14:28Peptide-based Identification of Functional Motifs and their Binding Partners
Published on: June 30, 2013
12.6K
相关概念视频
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
2.0K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.0K
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
668
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
668